Sunwin Stevia International Quick Ratio (SUWN) starting from the second quarter 2022 to second quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Sunwin Stevia International Inc.  (SUWN)

Sunwin Stevia International's Quick Ratio

SUWN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Sunwin Stevia International's Cash & cash equivalent grew by 194.24 % in the Q2 2022 sequentially, while Current Liabilities decreased, this led to improvement in Sunwin Stevia International's Quick Ratio to 0.15, Quick Ratio remained below Sunwin Stevia International Inc. average.

Within Major Pharmaceutical Preparations industry 607 other companies have achieved higher Quick Ratio than Sunwin Stevia International in second quarter 2022. While Quick Ratio total ranking has improved so far during the Q2 2022 to 4913, from total ranking in the first quarter 2022 at 4926.

Explain Quick Ratio?
How much Cash & cash equivalents SUWN´s has?
What are SUWN´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SUWN Quick Ratio (Oct 31 2022)
Q2		 (Jul 31 2022)
Q1		 (Apr 30 2022)
Q4		 (Jan 31 2022)
Q3		 (Oct 31 2021)
Q2
Y / Y Current Liabilities Change -29.88 % -26.43 % -8.08 % 50.13 % 46.13 %
Y / Y Cash & cash equivalent Change 297.06 % 40.62 % -79.49 % 406.96 % 76.17 %
Quick Ratio MRQ 0.15 0.04 0.01 0.04 0.03
SUWN's Total Ranking # 4913 # 4926 # 5940 # 5155 # 5790
Seq. Current Liabilities Change -21.56 % 7.64 % -27.41 % 14.4 % -17.7 %
Seq. Cash & cash equivalent Change 194.24 % 193.53 % -71.9 % 63.61 % 4.21 %



Quick Ratio second quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 608
Healthcare Sector # 1185
Overall Market # 4913


Quick Ratio Statistics
High Average Low
2094.5 158.81 0
(Jul 31 2011)   (Apr 30 2017)




Financial Statements
Sunwin Stevia International's Current Liabilities $ 19 Millions Visit SUWN's Balance sheet
Sunwin Stevia International's Cash & cash equivalent $ 3 Millions Visit SUWN's Balance sheet
Source of SUWN's Sales Visit SUWN's Sales by Geography


Cumulative Sunwin Stevia International's Quick Ratio

SUWN's Quick Ratio for the trailling 12 Months

SUWN Quick Ratio

 (Oct 31 2022)
12 Months		 (Jul 31 2022)
12 Months		 (Apr 30 2022)
12 Months		 (Jan 31 2022)
12 Months		 (Oct 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth -8.01 % 8.51 % 41.06 % 57.43 % 36.62 %
Y / Y Cash & cash equivalent TTM Growth 63.94 % 8.65 % -7.51 % 54.73 % 23.13 %
Quick Ratio TTM 0.05 0.03 0.03 0.04 0.03
Total Ranking TTM # 5924 # 5667 # 5687 # 5677 # 5667
Seq. Current Liabilities TTM Growth -7.72 % -7.67 % -1.71 % 9.84 % 8.86 %
Seq. Cash & cash equivalent TTM Growth 66.83 % 9.61 % -30.52 % 29.03 % 10.57 %

Quick ratio ranking by company, industry and sector >> Back to SUWN Financial Strength Comparisons >> Go to Compare SUWN Quick Ratio to its Competitors

On the trailing twelve months basis SUWN Cash & cash equivalent more than doubled by 297.06 % in Q2 2022 year on year, while Current Liabilities faded to $19 millions, this led to increase in in Sunwin Stevia International's Quick Ratio to 0.05, above SUWN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 619 other companies have achieved higher Quick Ratio than Sunwin Stevia International. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2022 from 5667 to 5924.

Explain Quick Ratio?
How much Cash & cash equivalents SUWN´s has?
What are SUWN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 620
Healthcare Sector # 1241
Within the Market # 5924


trailing twelve months Quick Ratio Statistics
High Average Low
0.04 0.03 0.01
(Apr 30 2021)   (Apr 30 2019)




Companies with similar Quick Ratio in the quarter ending Oct 31 2022, within Major Pharmaceutical Preparations Industry Quick RatioOct 31 2022 MRQ Cash & cash equivalentOct 31 2022 MRQ Current Liabilities
Jaguar Health Inc   0.39 $ 10.561  Millions$ 26.944  Millions
Eli Lilly And Company  0.39 $ 2,742.100  Millions$ 7,084.400  Millions
Avenue Therapeutics Inc   0.38 $ 0.217  Millions$ 0.573  Millions
Ensysce Biosciences Inc   0.38 $ 4.503  Millions$ 11.910  Millions
Abbvie Inc   0.36 $ 11,879.000  Millions$ 32,712.000  Millions
Catalent Inc   0.36 $ 345.000  Millions$ 969.000  Millions
Athersys Inc  0.36 $ 13.782  Millions$ 38.729  Millions
Elanco Animal Health Incorporated  0.35 $ 460.000  Millions$ 1,315.000  Millions
Optinose Inc   0.34 $ 61.080  Millions$ 177.795  Millions
Aytu Biopharma Inc  0.33 $ 23.811  Millions$ 73.204  Millions
Humanigen Inc  0.32 $ 24.725  Millions$ 76.387  Millions
Collegium Pharmaceutical Inc   0.32 $ 134.126  Millions$ 414.497  Millions
Gelesis Holdings Inc   0.31 $ 24.847  Millions$ 79.799  Millions
Ibio inc   0.31 $ 9.916  Millions$ 32.199  Millions
Allarity Therapeutics Inc   0.30 $ 3.946  Millions$ 12.955  Millions
Bausch Health Companies Inc   0.30 $ 486.000  Millions$ 1,600.000  Millions
Dmk Pharmaceuticals Corporation  0.30 $ 2.450  Millions$ 8.097  Millions
Grifols Sa  0.28 $ 613.736  Millions$ 2,190.549  Millions
Prestige Consumer Healthcare Inc   0.28 $ 42.442  Millions$ 152.308  Millions
Novartis Ag  0.27 $ 7,785.000  Millions$ 28,656.000  Millions
Baudax Bio Inc   0.27 $ 5.647  Millions$ 21.275  Millions
Gridai Technologies Corp  0.25 $ 1.657  Millions$ 6.694  Millions
Harrow Inc   0.23 $ 4.162  Millions$ 18.371  Millions
Ocean Biomedical Inc   0.23 $ 0.472  Millions$ 2.091  Millions
Elicio Therapeutics Inc   0.22 $ 1.839  Millions$ 8.182  Millions
Organon and Co   0.21 $ 499.000  Millions$ 2,328.000  Millions
Integrated Biopharma Inc  0.20 $ 1.168  Millions$ 5.814  Millions
Therapeuticsmd Inc   0.18 $ 27.080  Millions$ 152.304  Millions
China Pharma Holdings Inc  0.17 $ 2.086  Millions$ 12.628  Millions
Alimera Sciences Inc  0.16 $ 5.514  Millions$ 33.683  Millions

Date modified: 2026-09-02T17:35:56+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.